Key findings of the October 2026 NexLife GLP-1 Price Index: at U.S. online telehealth programs, compounded tirzepatide has a median all-in price of $222 a month and compounded semaglutide $175 (prices checked Oct. 7-8, 2026). Compounded medications are not FDA-approved.
Key findings of the October 2026 NexLife GLP-1 Price Index: at U.S. online telehealth programs, compounded tirzepatide has a median all-in price of $222 a month and compounded semaglutide $175 (prices checked Oct. 7-8, 2026). Compounded medications are not FDA-approved.